U.S. Banks Stock News

Bank OZK (OZK) has wrapped up FY 2025 with fourth quarter revenue of US$390.1 million and basic EPS of US$1.54, alongside full year trailing twelve month revenue of US$1.56 billion and EPS of US$6.20. Over the past six reported quarters, revenue has moved from US$375.2 million in Q4 2024 to US$390.1 million in Q4 2025, while quarterly EPS ranged from US$1.47 in Q1 2025 to US$1.60 in Q3 2025 and US$1.54 in the latest quarter. With a trailing net profit margin of 45.8% and a cost to income...

Greene County Bancorp (GCBC) opened Q2 2026 with total revenue of US$22.0 million and basic EPS of US$0.60, while trailing twelve month figures show revenue of US$82.0 million and EPS of US$2.15, alongside earnings growth of 37.4% over the last year. Over recent quarters, the company has seen revenue move from US$17.5 million and EPS of US$0.44 in Q2 2025 to US$22.0 million and EPS of US$0.60 in Q2 2026. The trailing net profit margin stands at 43.6% versus 38.3% last year, setting up an...

Leggett & Platt (NYSE:LEG) rejected an unsolicited acquisition proposal from Somnigroup as undervalued. The two companies have signed a non disclosure agreement and standstill to allow Somnigroup to conduct due diligence. Discussions are ongoing regarding a potential transaction, with no final terms agreed. Leggett & Platt enters these talks with a mixed recent track record in the market. The shares last closed at $12.59, with the stock up 14.7% over the past 30 days and 18.9% over the past...

Why Establishment Labs Holdings (ESTA) just grabbed investors’ attention Establishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth quarter and full year 2025, highlighting expected contributions from Motiva implant sales in the United States. See our latest analysis for Establishment Labs Holdings. At a share price of $64.63, Establishment Labs has recently seen a 13.15% 1 month share price decline. However, its 90 day share price return...

Gold Resource Corporation reported a past fourth‑quarter 2025 operational turnaround at its Don David Gold Mine, with higher‑grade ore from the Three Sisters area driving record silver sales and a shift toward silver‑weighted production. This operational improvement marks a meaningful change in the company’s revenue mix, increasing its exposure to silver‑linked performance at the Don David operation. We’ll now look at how this operational turnaround and Three Sisters’ higher‑grade ore shape...

If you are trying to work out whether NextDecade's current share price still reflects its long term potential, the key question is how the stock stacks up against its underlying value. The share price closed at US$4.86 recently, after a 7.4% decline over the last week and a 11.3% decline over the last month, with the one year return at a 46.3% loss and the five year return at 78.7%. Recent news around NextDecade has focused on its role in US liquefied natural gas projects and its efforts to...

If you are wondering whether VeriSign's share price still reflects fair value or if expectations have run ahead of the fundamentals, you are in the right place. VeriSign shares most recently closed at US$248.12, with returns of 0.7% over the last 7 days, 1.7% over the last 30 days, 3.2% year to date and 18.9% over 1 year, while the 3 and 5 year returns sit at 16.1% and 27.7% respectively. These price moves sit against a backdrop of ongoing attention on domain infrastructure providers and the...

As the United States market experiences a rebound following recent volatility, with major indices like the Dow Jones and S&P 500 showing significant gains after addressing geopolitical tensions, investors are keeping a close eye on high-growth sectors. In this dynamic environment, identifying tech stocks with strong fundamentals and innovative potential can be crucial for navigating the opportunities presented by such market fluctuations.

Amid recent volatility in the U.S. markets, with major indices like the Dow Jones and S&P 500 experiencing significant fluctuations due to geopolitical tensions and economic policy shifts, investors are keenly observing opportunities that may arise from these movements. In such an environment, identifying stocks that are potentially undervalued based on intrinsic value estimates can offer a strategic advantage, as they might provide growth potential when market conditions stabilize.

Major stock indexes saw a significant rebound recently, with the Dow Jones adding 450 points after President Trump ruled out the use of force in Greenland. Amidst this backdrop of market volatility and geopolitical tensions, investors are exploring opportunities beyond traditional stocks. Penny stocks, often representing smaller or newer companies, continue to attract attention for their potential value and growth prospects. In this article, we explore three penny stocks that showcase...

Reverse split reshapes Ozop Energy Solutions share structure Ozop Energy Solutions (OZSC) is carrying out a 1 for 5,000 reverse stock split effective January 21, 2026. This move sharply consolidates its share count and changes the trading price per share. This type of corporate action does not alter the company’s reported revenue of US$0.32 million or its loss of US$6.95 million, but it can influence liquidity, trading behavior, and how different investors view the stock. See our latest...

Omega Healthcare Investors (NYSE:OHI) is showing a strong technical breakout pattern, pointing to renewed investor interest in the healthcare REIT space. The breakout aligns with a confirmed uptrend and a solid technical setup that traders may use as a rule-based entry signal. With shares last closing at $45.04, the move is drawing fresh attention from investors watching healthcare focused real estate names. For context, Omega Healthcare Investors has delivered a 28.1% return over the past...

If you are wondering whether Origin Bancorp's current share price reflects solid value or hidden risk, it helps to start by lining up the recent performance with what you are actually paying for the business. The stock last closed at US$39.70, with returns of 1.1% over 7 days, 2.1% over 30 days, 5.5% year to date, 13.1% over 1 year, 8.7% over 3 years, and 47.1% over 5 years. This gives useful context before comparing the price to fundamentals. Recent coverage has focused on Origin Bancorp's...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Rivulet Entertainment (OTCPK:RIVF) opened 2026 with a quiet top line and a deeper loss, reporting Q1 total revenue of US$0 and a net loss of US$0.97 million, which translated to basic EPS of US$0.01. Over recent quarters the company has seen revenue move between US$0 and US$10 million, while quarterly basic EPS ranged from about US$0.00 to US$0.03 in losses. This sets a backdrop where margin pressure rather than sales growth is front and center for investors parsing this update. See our full...

If you are wondering whether PACS Group still offers good value after its strong run, or if most of the opportunity is already reflected in the share price, this article is designed to help you make sense of where the stock stands today. The share price closed at US$35.69, with a 15.3% decline over the last 7 days and a 1.9% decline over 30 days, but a 155.7% return over the past year suggests that the story has been far from quiet. Recent coverage has focused on PACS Group as a listed...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

If you are wondering whether Novavax's share price still reflects its true worth, you are not alone. This article will walk through what the current valuation really says. Over the past month the stock is up 23.1%, even though the 7 day return is a 5.4% decline and the 1 year return sits at a 6.9% loss after much steeper falls of 29.0% over 3 years and 93.6% over 5 years. Recent moves in Novavax shares have been framed by ongoing interest in vaccine related companies and renewed investor...

Why REV Group is on investors’ radar today REV Group (REVG) has drawn fresh attention after recent trading left the stock with mixed short term returns but stronger gains over the month and past 3 months, prompting investors to reassess its valuation. See our latest analysis for REV Group. Despite a 2.1% one-day share price decline and some recent softness over the past week, REV Group’s 30-day share price return of 8.4% and very large 5-year total shareholder return suggest longer-term...

If you are wondering whether ServisFirst Bancshares at around US$76.33 is offering good value right now, you are not alone. This article is set up to help you make sense of that question. The stock has returned 1.6% over the past week and 5.1% over the last 30 days, while the 1 year return of negative 13.6% contrasts with longer term gains of 24.6% over 3 years and 89.1% over 5 years. Recent attention on regional banks, and ServisFirst Bancshares in particular, has centered on how investors...

Elastic (NYSE:ESTC) has rolled out an upgraded Elastic Cloud Serverless platform on Amazon Web Services. The release introduces higher indexing throughput and lower search latency through the use of AWS Graviton instances. The upgrade is live immediately for all AWS based serverless users, with no manual changes required. The company highlights benefits for search, observability, and AI/ML workloads that rely on larger and more complex data volumes. For context, Elastic focuses on search,...

In January 2026, Tenaya Therapeutics outlined past and upcoming 2026 milestones for its TN-201 and TN-401 gene therapy programs, including interim MyPEAK-1 data, additional RIDGE-1 updates, and plans to seek regulatory alignment on potential pivotal studies. A key insight is that both programs target genetically defined cardiac conditions with U.S. FDA designations and planned data readouts that could clarify each therapy’s clinical risk profile and development path. We will now examine how...

If you are trying to work out whether Axcelis Technologies is still a reasonable entry point or already pricing in a lot of good news, its current valuation story is worth a closer look. The share price recently closed at US$88.16, with returns of 6.6% over the last 30 days and 23.4% over the last year, although the stock has seen a 9.2% decline over the past week and an 18.3% decline over three years, with a 135.5% gain over five years and a 2.4% return year to date. Recent coverage has...

As the U.S. market grapples with heightened geopolitical tensions and the threat of new tariffs, major indices like the Nasdaq and S&P 500 have experienced significant declines, reflecting broader market unease. Amidst this volatility, investors often seek stocks with strong fundamentals and innovative potential that can navigate such uncertain environments effectively.